PRODUCT COMPRISING A SIGNAL TRANSDUCTION INHIBITOR OF HETEROTRIMERIC PROTEINS IN ASSOCIATION WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF CANCER

摘要

A novel product comprises heterotrimeric G protein signal transduction inhibitor(s) (I) and other anticancer agent(s) (II) selected from prenyl transferase inhibitors, taxol (or analogs), gemcitabin and camptothecin (or analogs), for simultaneous, separate or successive therapeutic use in the treatment of cancer.